Endobronchial ultrasound‐guided re‐biopsy of non–small cell lung cancer with acquired resistance after EGFR tyrosine kinase inhibitor treatment by Kyung Soo Hong, Jinmo Cho, Jong Geol Jang, Min Hye Jang, June Hong Ahn

Subjects: Get full text

RET fusion mutation detected by re-biopsy 7 years after initial cytotoxic chemotherapy: A case report by Kei Morikawa, Hiroshi Handa, Junko Ueno, Hajime Tsuruoka, Takeo Inoue, Naoki Shimada, Junki Koike, Seiji Nakamura, Yoshiharu Sato, Masamichi Mineshita

Subjects: Get full text

Short progression‐free survival of ALK inhibitors sensitive to secondary mutations in ALK‐positive NSCLC patients by Naoki Haratake, Takashi Seto, Shinkichi Takamori, Ryo Toyozawa, Kaname Nosaki, Naoko Miura, Taro Ohba, Gouji Toyokawa, Kenichi Taguchi, Masafumi Yamaguchi, Mototsugu Shimokawa, Mitsuhiro Takenoyama

Subjects: Get full text

Feasibility of tissue re-biopsy in non-small cell lung cancers resistant to previous epidermal growth factor receptor tyrosine kinase inhibitor therapies by Sakurako Uozu, Kazuyoshi Imaizumi, Teppei Yamaguchi, Yasuhiro Goto, Kenji Kawada, Tomoyuki Minezawa, Takuya Okamura, Ken Akao, Masamichi Hayashi, Sumito Isogai, Mitsushi Okazawa, Naozumi Hashimoto, Yoshinori Hasegawa

Subjects: “…Re-biopsy…”
Get full text

Re‐biopsy and liquid biopsy for patients with non‐small cell lung cancer after EGFR‐tyrosine kinase inhibitor failure by Juan Zhou, Chao Zhao, Jing Zhao, Qi Wang, Xiangling Chu, Jiayu Li, Fei Zhou, Shengxiang Ren, Xuefei Li, Chunxia Su, Caicun Zhou

Subjects: Get full text

Comparison of sampling methods for next generation sequencing for patients with lung cancer by Kei Kunimasa, Shingo Matsumoto, Kazumi Nishino, Keiichiro Honma, Noboru Maeda, Hanako Kuhara, Motohiro Tamiya, Takako Inoue, Takahisa Kawamura, Toru Kimura, Tomohiro Maniwa, Jiro Okami, Koichi Goto, Toru Kumagai

Subjects: Get full text

The impact of the tumor shrinkage by initial EGFR inhibitors according to the detection of EGFR-T790M mutation in patients with non-small cell lung cancer harboring EGFR mutations by Akihiro Yoshimura, Tadaaki Yamada, Naoko Okura, Takayuki Takeda, Wataru Furutani, Yutaka Kubota, Shinsuke Shiotsu, Osamu Hiranuma, Naoya Nishioka, Yusuke Chihara, Nobuyo Tamiya, Yoshiko Kaneko, Junji Uchino, Koichi Takayama

Subjects: Get full text

Comparison of Different EGFR Gene Mutation Status in Patients with Metastatic Non-Small Lung Cancer After First-Line EGFR-TKIs Therapy and Analyzing Its Relationship with Efficacy... by Yuan C, Jiang H, Jiang W, Wang H, Su C, Zhou S

Subjects: Get full text

Utility of needle biopsy in centrally located lung cancer for genome analysis: a retrospective cohort study by Kei Kunimasa, Shingo Matsumoto, Keiichiro Honma, Motohiro Tamiya, Takako Inoue, Takahisa Kawamura, Satoshi Tanada, Akito Miyazaki, Ryu Kanzaki, Tomohiro Maniwa, Jiro Okami, Yuji Matsumoto, Koichi Goto, Kazumi Nishino

Subjects: Get full text

Frequency of the acquired resistant mutation T790 M in non-small cell lung cancer patients with active exon 19Del and exon 21 L858R: a systematic review and meta-analysis by Zan-Feng Wang, Sheng-Xiang Ren, Wei Li, Guang-Hui Gao

Subjects: Get full text

Case Report: A Rare Case of Metachronous Multiple Primary Lung Cancers in a Patient With Successful Management by Switching From Anti-PD-1 Therapy to Anti-PD-L1 Therapy by Xinqing Lin, Guihuan Qiu, Fang Li, Haiyi Deng, Yinyin Qin, Xiaohong Xie, Juhong Jiang, Yong Song, Yong Song, Ming Liu, Chengzhi Zhou

Subjects: Get full text

Next‐generation sequencing of tissue and circulating tumor DNA: Resistance mechanisms to EGFR targeted therapy in a cohort of patients with advanced non‐small cell lung cancer by Yujun Zhang, Liwen Xiong, Fangfang Xie, Xiaoxuan Zheng, Ying Li, Lei Zhu, Jiayuan Sun

Subjects: Get full text

Factors associated with outcomes of second-line treatment for EGFR-mutant non-small-cell lung cancer patients after progression on first- or second-generation EGFR-tyrosine kinase... by Cheng-Yu Chang, Cheng-Yu Chang, Chung-Yu Chen, Chung-Yu Chen, Shih-Chieh Chang, Shih-Chieh Chang, Shih-Chieh Chang, Ching-Yi Chen, Yi-Chun Lai, Yi-Chun Lai, Chun-Fu Chang, Chun-Fu Chang, Yu-Feng Wei, Yu-Feng Wei

Subjects: Get full text

Redetermination of PD-L1 expression after chemio-radiation in locally advanced PDL1 negative NSCLC patients: retrospective multicentric analysis by Patrizia Ciammella, Salvatore Cozzi, Paolo Borghetti, Marco Galaverni, Valerio Nardone, Maria Paola Ruggieri, Matteo Sepulcri, Vieri Scotti, Alessio Bruni, Francesca Zanelli, Roberto Piro, Elena Tagliavini, Andrea Botti, Federico Iori, Federico Iori, Emanuele Alì, Chiara Bennati, Marcello Tiseo

Subjects: Get full text

Comparative study of the PD-L1 expression and CD8+ tumor-infiltrating lymphocyte between surgically resected and matched re-biopsy specimens in recurrent non-small cell lung cancer by Shimizu K, Okita R, Saisho S, Maeda A, Nojima Y, Nakata M

Subjects: “…non-small cell lung cancer (NSCLC) programmed cell death ligand 1 (PD-L1) tumor-infiltrating T lymphocytes tumor immune-microenvironment (TIME) re-biopsy…”
Get full text

Factors associated with the progression of mesangial lesions in IgA nephropathy: A comparative analysis of renal re-biopsies by Yetong Li, Shimin Jiang, Hongmei Gao, Yue Yang, Xiaorong Liu, Wenge Li

Subjects: Get full text